HomeInsightsStock Comparison

Kaya Ltd vs Suven Life Sciences Ltd Stock Comparison

Kaya Ltd vs Suven Life Sciences Ltd Stock Comparison

Last Updated on: Jul 18, 2025

Key Highlights

  • The Latest Trading Price of Kaya Ltd is ₹ 450.45 as of 18 Jul 10:41.
  • The P/E Ratio of Kaya Ltd changed from 3.7 on March 2025 to 3.7 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Suven Life Sciences Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Kaya Ltd changed from ₹ 145.53 crore on March 2020 to ₹ 305.7 crore on March 2025 . This represents a CAGR of 13.17% over 6 yearsThe Market Cap of Suven Life Sciences Ltd changed from ₹ 272.38 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The revenue of Kaya Ltd for the Mar '25 is ₹ 63.28 crore as compare to the Dec '24 revenue of ₹ 74.5 crore. This represent the decline of -15.06% The revenue of Suven Life Sciences Ltd for the Mar '25 is ₹ 2.69 crore as compare to the Dec '24 revenue of ₹ 3.24 crore. This represent the decline of -16.98%.
  • The ebitda of Kaya Ltd for the Mar '25 is ₹ 10.29 crore as compare to the Dec '24 ebitda of ₹ 21.14 crore. This represent the decline of -51.32% The ebitda of Suven Life Sciences Ltd for the Mar '25 is ₹ -42.6 crore as compare to the Dec '24 ebitda of ₹ -37.58 crore. This represent the growth of 13.36%.
  • The net profit of Kaya Ltd changed from ₹ -10.38 crore to ₹ -7.02 crore over 8 quarters. This represents a CAGR of -17.76% The net profit of Suven Life Sciences Ltd changed from ₹ -24.09 crore to ₹ -43.94 crore over 8 quarters. This represents a CAGR of 35.06% .
  • The Dividend Payout of Kaya Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Suven Life Sciences Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Kaya Ltd

  • Kaya Limited was formerly incorporated as Kaya Skin Care Ltd on March 27, 2003.
  • The Company name was changed from Kaya Skin Care Limited to Kaya Limited in March, 2012.
  • The Company, headquartered in Mumbai, carries on Skin Care Business in India and through its subsidiary in Middle East region.
  • Up to March 31, 2013, the Kaya Business was conducted as subsidiaries of Marico Limited.
  • Following the demerger, of Kaya business from Marico Limited in September, 2013 the Kaya Business has been conducted by the Company and its subsidiaries. Kaya is a pioneer in aesthetic dermatology in India and the Middle East.

About Suven Life Sciences Ltd

  • Suven Life Sciences Limited (Formerly known as Suven Pharmaceuticals Ltd) was incorporated in March, 1989.
  • The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003.
  • Promoted by Sudharani Jasti and Venkateswarlu Jasti, the Company began operations in 1989 as specialty chemicals provider. The Company is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
  • Suven has a wholly owned subsidiary, Suven Neurosciences, Inc., USA, focused on clinical development activities of Suven molecules from phase 2, Proof-of-Concept (POC) studies. The Company is in the business of Contract Research And Manufacturing Services (CRAMS), catering to the needs of global life science industry and fine chemical majors.

Kaya Ltd News Hub

News

Kaya schedules AGM

Kaya announced that the 22th Annual General Meeting(AGM) of the company will be held on 5 ...

Read more

12 Jul 2025 17:28

News

Kaya to conduct EGM

Kaya announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on...

Read more

27 Jun 2025 11:08

News

Kaya announces board meeting date

Kaya will hold a meeting of the Board of Directors of the Company on 26 June 2025. Powered...

Read more

24 Jun 2025 14:36

News

Kaya to discuss results

Kaya will hold a meeting of the Board of Directors of the Company on 28 May 2025. Powered ...

Read more

20 May 2025 11:08

News

Kaya Ltd leads gainers in 'B' group

Zodiac Energy Ltd, Banco Products (India) Ltd, Foods & Inns Ltd and BLS E-Services Ltd are...

Read more

19 May 2025 12:15

News

Kaya schedules board meeting

Kaya will hold a meeting of the Board of Directors of the Company on 28 January 2025. Powe...

Read more

17 Jan 2025 17:26

Suven Life Sciences Ltd News Hub

News

Suven Life Sciences updates on Phase-2b clinical trial of Ropanicant

Suven Life Sciences announced that the first patient has been randomized in its Phase-2b c...

Read more

16 Jul 2025 13:35

News

Suven Life Sciences Ltd Slides 3.06%, BSE Healthcare index Shed 1.34%

Suven Life Sciences Ltd fell 3.06% today to trade at Rs 220. The BSE Healthcare index is d...

Read more

23 Jun 2025 09:30

News

Suven Life Sciences schedules EGM

Suven Life Sciences announced that an Extra Ordinary General Meeting (EGM) of the Company ...

Read more

14 May 2025 11:52

News

Suven Life Sciences to conduct AGM

Suven Life Sciences announced that the 36th Annual General Meeting(AGM) of the company wil...

Read more

14 May 2025 11:52

News

Suven Life Sciences to declare Quarterly Results

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 13 May...

Read more

07 May 2025 10:54

News

Suven Life Sciences to convene board meeting

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 24 Jan...

Read more

17 Jan 2025 10:26

SWOT Analysis Of Kaya Ltd

Strength

2

S

Weakness

2

W

Opportunity

1

O

Threats

0

T

SWOT Analysis Of Suven Life Sciences Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Kaya Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Suven Life Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Kaya Ltd and Suven Life Sciences Ltd

Which company has a larger market capitalization, Kaya Ltd or Suven Life Sciences Ltd?

Market cap of Kaya Ltd is 578 Cr while Market cap of Suven Life Sciences Ltd is 6,306 Cr

What are the key factors driving the stock performance of Kaya Ltd and Suven Life Sciences Ltd?

The stock performance of Kaya Ltd and Suven Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kaya Ltd and Suven Life Sciences Ltd?

As of July 18, 2025, the Kaya Ltd stock price is INR ₹441.65. On the other hand, Suven Life Sciences Ltd stock price is INR ₹289.2.

How do dividend payouts of Kaya Ltd and Suven Life Sciences Ltd compare?

To compare the dividend payouts of Kaya Ltd and Suven Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions